An independent guide to domperidone and Motilium
If you have landed on this page, there is a good chance you searched for something like "what is domperidone," "domperidone breastfeeding," or "why isn't domperidone available in the US." Those are all reasonable questions about a medicine that is approved and widely used in dozens of countries, yet remains unapproved in the United States. This site was built to answer those questions in plain language, without exaggeration and without trying to sell you anything.
Domperidone Motilium Guide does not manufacture, distribute, ship, or dispense any medication. We are not a pharmacy, a telehealth clinic, or a manufacturer's marketing site. Every page here is written to be read alongside, not instead of, advice from your own doctor or pharmacist. Content is reviewed for accuracy by a licensed pharmacist — see our reviewer page for credentials and methodology.
Because domperidone sits in an unusual regulatory position — approved abroad, unapproved in the U.S., and discussed constantly online for uses ranging from digestive symptoms to lactation support — it attracts a lot of confusing and sometimes inaccurate information. This guide tries to separate what is well established from what is still debated, and to flag safety warnings clearly rather than downplaying them.
What is domperidone?
Domperidone is the generic (non-proprietary) name for a medicine most commonly sold internationally under the brand name Motilium, along with several other regional brand names. Pharmacologically, it belongs to a class of drugs called dopamine D2-receptor antagonists, and it is often described as a "prokinetic" agent because of its effect on the movement of the digestive tract. It was first developed and studied in the late 1970s and has since been approved for use in more than 100 countries, including Canada, the United Kingdom, most of the European Union, and Australia.
One detail that often confuses people is the relationship between domperidone and metoclopramide, another prokinetic dopamine-blocker. The two drugs share some effects on the gut but differ meaningfully in how well they cross into the brain, which affects both their side-effect profile and the way regulators have treated each one. We cover this comparison, along with the basic mechanism of action, dosage forms, and how domperidone differs from the brand name Motilium, in more detail on our dedicated page, What Is Domperidone?
It is worth repeating that "Motilium" is simply the most recognized trade name for domperidone in the markets where it is sold, in much the same way that "Tylenol" is a trade name for acetaminophen. The active ingredient, and the safety considerations that come with it, are the same regardless of which name appears on the box.
Why people look into domperidone
Search interest in domperidone tends to cluster around three broad themes: chronic digestive symptoms, general nausea, and lactation support. On the digestive side, domperidone has been studied for gastroparesis (delayed stomach emptying) and for symptoms such as bloating, early fullness, and nausea that can accompany it. It is sometimes discussed alongside other prokinetic and anti-nausea options as part of a broader conversation a patient has with their gastroenterologist.
The lactation-related interest is large enough that we have given it its own page, because the evidence, the regulatory warnings, and the practical considerations are genuinely different from the digestive-symptom use case. In short: some clinicians outside the U.S. prescribe domperidone off-label to support milk supply, but this use is specifically flagged as higher-risk by regulators including the FDA, and it deserves a dedicated, careful explanation rather than a passing mention.
We go through the documented and off-label use cases, what clinical literature actually says about effectiveness, and what questions to bring to a physician, on our Domperidone Uses page.
It helps to understand where domperidone sits relative to other options a gastroenterologist might discuss. Metoclopramide is the other prokinetic most commonly compared to it and is FDA-approved, but it carries its own well-known warning about movement disorders with long-term use, because it crosses into the brain more readily. Other approaches for nausea, such as certain antiemetics, work through different receptor pathways entirely and are not interchangeable with domperidone. None of this is a recommendation for or against any particular option — it is simply context for a conversation that should happen with a physician who knows a patient's full history, current medications, and cardiac risk factors.
Domperidone and breastfeeding
Few domperidone topics generate as many search queries as breastfeeding and milk supply. Outside the U.S., some lactation specialists and physicians have prescribed domperidone off-label when a parent has a confirmed low milk supply and other approaches have not helped. The rationale is that domperidone raises prolactin levels as a secondary effect of blocking dopamine receptors.
That said, this is exactly the use case regulators have been most cautious about. Because domperidone can affect heart rhythm (specifically, prolonging what is called the QT interval) at higher doses or in people with certain risk factors, health agencies including the FDA have issued public warnings advising against using domperidone to increase milk supply outside of careful medical supervision. This does not mean the conversation is closed everywhere — policies vary by country — but it does mean anyone considering this route should have a real conversation with their physician and a lactation consultant about their personal cardiac risk factors, current medications, and alternatives, rather than starting on their own.
Our Domperidone and Breastfeeding page walks through the available research, the specific safety warnings, dosing patterns discussed in clinical literature, and questions worth asking a healthcare provider before pursuing this path.
How domperidone is typically taken
Where domperidone is approved, it is most commonly supplied as an oral tablet, with 10 mg being the strength most frequently referenced in product labeling and clinical literature, though other strengths and formulations (including liquid suspensions in some markets) exist. It is usually taken shortly before meals, reflecting its role in supporting digestive motility around eating.
Exact dosing, how many times a day it is taken, and how long a course lasts vary by country, by the condition being addressed, and by individual patient factors such as kidney or liver function. This is one area where generic guidance is genuinely less useful than a conversation with the prescriber who knows a patient's full history. Our Domperidone Dosage & Administration page summarizes how dosing is generally structured in places where the drug is approved, without presenting it as personalized medical instruction.
Regulators in several countries have also tightened dosing guidance over time as more safety data accumulated. The general pattern has been toward lower maximum daily doses, shorter recommended courses (often a matter of days to a couple of weeks rather than open-ended use), and closer monitoring for people with any cardiac history. This is a useful reminder that dosing information found online, including on this site, reflects general labeling trends rather than a fixed, universal regimen.
Safety considerations and warnings
Domperidone's safety story is a major reason its regulatory status differs so much from country to country, so we want to be direct about it here rather than saving it for a secondary page. The most significant concern is a dose-related risk of QT-interval prolongation, a change in the heart's electrical cycle that can, in rare cases, lead to serious arrhythmias. This risk became apparent decades ago primarily with an intravenous (IV) formulation given at high doses, which was withdrawn from use, but regulators including the European Medicines Agency and the UK's MHRA later reviewed the oral formulation as well and added restrictions: lower recommended doses, shorter recommended courses, and clear contraindications for people with certain heart conditions or who take specific interacting medications.
Commonly reported side effects with oral domperidone at approved doses include dry mouth, headache, and gastrointestinal discomfort. Less common but more serious concerns include the cardiac effects mentioned above and, because domperidone is a dopamine antagonist, a small risk of movement-related side effects, though these are far more strongly associated with drugs that cross into the brain more readily.
Domperidone is also affected by drug interactions, particularly with medicines that strongly inhibit the liver enzyme CYP3A4 (certain antifungal and antibiotic medications, for example), because these can raise domperidone levels and increase cardiac risk. A full, current medication list should always be reviewed by a pharmacist or physician before considering domperidone in any form. We cover the complete warning list, contraindications, and interaction categories on our Side Effects & Safety page.
Questions worth asking a doctor or pharmacist
Because so much of the nuance here depends on individual health history, we think the most useful thing this site can do is help you prepare for a better conversation with a licensed professional, rather than try to replace one. Consider bringing up:
- Whether you have any personal or family history of heart rhythm problems, fainting, or unexplained sudden cardiac events
- A complete list of current prescription drugs, over-the-counter products, and supplements, so interactions can be checked
- What specific symptom or goal you are hoping domperidone would address, and what has already been tried
- Whether an FDA-approved alternative might reasonably address the same symptoms
- If lactation support is the goal, whether a lactation consultant should be involved alongside your physician
Is domperidone available in the United States?
This is probably the single most common question that brings people to this site, so we will answer it plainly: domperidone is not approved by the FDA for any indication, and it is not legally sold in U.S. retail or online pharmacies. There is no over-the-counter version, and no FDA-approved prescription version either — the situation is different from many other prescription drugs that are simply "Rx-only" in the U.S. but still approved.
The regulatory history matters here. Domperidone's manufacturer never pursued full FDA approval in the United States, and separately, the FDA's own review of high-dose intravenous domperidone in the 1980s identified serious cardiac risks, which contributed to the agency's continued caution about the oral form as well. Meanwhile, other regulators — in Canada, the UK, the EU, Australia, and elsewhere — did approve oral domperidone, generally with the dose and duration restrictions described above.
For patients in the U.S. who have a genuine medical need (most commonly for chronic gastroparesis that has not responded to other options), the established legitimate pathway is through a physician who applies to the FDA for authorization under its Investigational New Drug (expanded access) framework on that patient's behalf. If approved, the medicine is then prepared by a specialized, registered compounding pharmacy under that specific authorization. This is a physician-driven, case-by-case process, not a retail purchase, and it is not something this website facilitates, brokers, or sells access to.
We go into more depth on this regulatory history, the expanded-access process, how it differs from simply "getting a prescription" for an approved drug, and what the situation looks like in other English-speaking countries such as Canada and the UK, on our Legal Status & Availability page.
How we review this content
Every page on this site is reviewed by Dr. Michael Rio, PharmD, a licensed pharmacist affiliated with Northeastern University's Behrakis Health Sciences Center. Our review process focuses on whether the medical facts are current and accurately represented, whether safety warnings are given appropriate weight, and whether language stays descriptive rather than promotional. Reviewer sign-off does not create a doctor-patient relationship and is not a substitute for individualized medical advice; it is a quality check on the accuracy of published information.
Frequently asked questions
What is domperidone used for?
Domperidone is a prokinetic, dopamine-blocking medicine studied mainly for digestive symptoms such as nausea, bloating, and slow stomach emptying (gastroparesis). In some countries it is also used off-label, under medical supervision, to support milk supply during breastfeeding.
Is domperidone available over the counter in the United States?
No. Domperidone is not approved by the FDA for any use and is not sold over the counter in the U.S. Even in the many countries where it is approved, it is a prescription-only medicine, not an over-the-counter product.
Why isn't domperidone FDA-approved?
The manufacturer never completed the U.S. approval process. Separately, the FDA identified a risk of serious heart rhythm problems linked to high-dose intravenous domperidone in the 1980s, which reinforced the agency's cautious stance toward the oral form as well.
How does domperidone work?
Domperidone blocks dopamine D2 receptors in the gut and in the brain's chemoreceptor trigger zone. This combination is thought to speed up stomach emptying and reduce the signals that cause nausea, without crossing the blood-brain barrier as readily as some older similar drugs.
Is domperidone safe while breastfeeding?
Some clinicians prescribe domperidone off-label to support milk supply, but health authorities including the FDA have warned against this use because of potential cardiac risks to the parent. Anyone considering it should discuss the specific risks and alternatives with their own physician and a lactation consultant.
How can someone in the U.S. legally access domperidone?
Because domperidone is not FDA-approved, the main legitimate pathway in the U.S. is through a physician who applies to the FDA's Investigational New Drug (Expanded Access) program on a patient's behalf, dispensed by a registered compounding pharmacy. This guide does not sell, ship, or broker domperidone in any form.
What is domperidone maleate?
Domperidone maleate is simply the maleate salt form of domperidone used in most tablet formulations for stability and absorption reasons. Clinically, it is discussed the same way as domperidone itself; the "maleate" label mainly reflects the chemical form used in manufacturing.
What are the most common side effects of domperidone?
In clinical literature, the most frequently reported side effects at approved doses include dry mouth, headache, and mild gastrointestinal discomfort. Less common but more serious effects involve heart rhythm changes, which is why cardiac history and interacting medications are screened before it is prescribed.
Editorial note: nothing on this site is medical advice. Domperidone carries documented cardiac safety warnings, and its legal status varies by country. Always talk with a licensed doctor or pharmacist before making any decision related to this or any other medicine.